This chemokine is highly expressed in SS patients; it has been shown that this chemokine recruits immunosuppressive CXCR3 (the cognate receptor)-expressing CD4 C/CD8 C effector T cells and Tregs. This evidence concerns the gene CXCR3 and synovial sarcoma.